RSM's capital markets team has successfully acted as reporting accountants for Electrical Geodesics Inc. on its IPO to the AIM market.
Based in Eugene, Oregon, USA, Electrical Geodesics Inc. was founded in 1992 and is a leading medical device company. EGI designs, develops and commercialises a range of non-invasive neurodiagnostic products used to monitor and interpret brain activity in a broad range of applications, including epilepsy, autism, stroke, traumatic brain injury and sleep disorders.
EGI has achieved rapid growth in recent years with revenues of $12.5m for the year ended 31 December 2012. The fundraising of £8.0m will be used primarily to support an increase in sales and marketing activities to establish further its products in its key markets.
What RSM did
RSM’s capital markets team has successfully acted as reporting accountants for Electrical Geodesics Inc. on its IPO to the AIM market.
'EGI is delighted to have joined the London AIM market which has brought access to the public market we feel is best-suited to a company of our size, international focus and growth aspirations. RSM as reporting accountants helped smooth the process and removed many of the obstacles we might have faced as a small US company transitioning to the world of IFRS based public reporting.'
Christine Soden, Finance Director, Electrical Geodesics Inc.
Paul Watts, Partner
Ed Pipe, Associate Director